The short version
- What it doesThis is one of the few supplements on the site with a real, specific, sixty-year-old mechanism, and it starts with a virus that cannot do without one amino acid. Herpes simplex was grown in human cells in chemically defined media and its amino acid requirements mapped one at a time.
- Who it is forCold-sore/HSV support, collagen and general amino balance.
- What to watchGI upset and diarrhea at high doses (above about 6 g).
How L-Lysine works
An essential amino acid that competes with arginine for the same transport and incorporation pathways. Herpes simplex requires arginine for capsid protein synthesis, so raising the lysine-to-arginine ratio limits viral replication.
Read the rest of how it works
Lysine is also required for collagen cross-linking via lysyl oxidase and for carnitine synthesis.
L-Lysine: serving, timing and spacing
- Suggested serving
- 1–3 g daily (higher during outbreaks) away from arginine-rich meals.
- How often
- Daily
- When
- Away from
- Spacing that matters for safety
- 1–3 g daily (higher during outbreaks) away from arginine-rich meals.
General referenceA general reference intake for education, not a prescription. The label on the product you buy is the final word.
Good to know: Works by opposing arginine — pairs poorly with arginine supplements for this specific use.
Research on L-Lysine4 evidence notes: clinical, correlative, theoretical
Each note sits under the kind of evidence it stands on. A thin or missing trial means nobody has run it yet, not that it doesn’t work. How the evidence tiers work
Human clinical evidence
RCTs support reduced frequency/severity of recurrent cold sores.
Required for collagen cross-linking and carnitine production.
Correlative data
Higher lysine:arginine ratios are associated with fewer HSV recurrences.
Theoretical / extrapolated benefits
Broader immune and bone-support roles are mechanistically reasonable but less proven.
Sources read for this page
- Tankersley RW. Amino acid requirements of herpes simplex virus in human cells. Journal of Bacteriology 1964 · PMID 14127578
- Griffith RS. Success of L-lysine therapy in frequently recurrent herpes simplex infection. Dermatologica 1987 · PMID 3115841
- Simon CA. Failure of lysine in frequently recurrent herpes simplex infection. Archives of Dermatology 1985 · PMID 3919651
- Mailoo VJ. Lysine for Herpes Simplex Prophylaxis: A Review of the Evidence. Integrative Medicine (Encinitas) 2017 · PMID 30881246
- Flodin NW. The metabolic roles, pharmacology, and toxicology of lysine. Journal of the American College of Nutrition 1997 · PMID 9013429
- NIH Office of Dietary Supplements. L-Lysine (Thorne) — Supplement Facts, DSLD ID 209552, recorded off market 30 November 2022. NIH Dietary Supplement Label Database, retrieved 5 September 2026
L-Lysine, the deep readThe mechanism, cell to human, which form, how you would know
What L-Lysine actually does
This is one of the few supplements on the site with a real, specific, sixty-year-old mechanism, and it starts with a virus that cannot do without one amino acid. Herpes simplex was grown in human cells in chemically defined media and its amino acid requirements mapped one at a time. Remove arginine and virus production collapses while the host cell carries on Tankersley 1964. That is the founding experiment, it was published in 1964, and every lysine bottle on every shelf descends from it.
Why arginine specifically, and this part is compositional rather than incidental. The HSV-1 genome is around 68% G+C. Arginine is encoded by CGN and AGA/AGG codons, and the GC-rich ones dominate in a GC-rich genome, so the virus's late structural proteins — capsid and tegument — are arginine-rich by construction. A virus built out of arginine-heavy proteins has an arginine demand that scales with how fast it is replicating.
Lysine's proposed action is competition at a named transporter. Lysine and arginine are both cationic amino acids and both are carried by the system y+ transporters, CAT-1 (the gene SLC7A1) and its relatives, at the cell membrane and in the intestine. They compete for the same carrier. Raising the lysine-to-arginine ratio in plasma should therefore lower arginine delivery into cells, and that is the whole pharmacological argument.
Here is the hole in it, stated honestly. The competition is documented at the transporter. The consequence — less arginine inside a latently infected trigeminal ganglion neuron, or inside lip epithelium during reactivation — has never been demonstrated in a human being. Nobody has measured intracellular arginine at the site of replication in a person taking lysine. The chain from 1964 to your capsule has one unmeasured link in the middle, and it is the link that matters most.
And there is a dose problem built into the biology. Lysine is an essential amino acid; a normal protein intake supplies several grams a day already Flodin 1997. A 1 g capsule is a modest addition to a pool that is being refilled by every meal, which is precisely why the trials that reported anything used 3 g a day, and why the review's threshold sits where it does.
Cell, rodent, human — and where it stops
Cells. Human cells, defined medium, arginine omission, virus yield collapses Tankersley 1964. Clean and reproducible.
The positive human trial, in full. A double-blind, placebo-controlled, multicentre trial randomized 27 people to L-lysine and 25 to placebo, at 1,000 mg per dose three times a day — 3 g/day — for six months. The lysine group had 2.4 fewer herpes simplex infections over that period (p < 0.05), with reduced symptom severity and shorter healing time, also at p < 0.05 Griffith 1987.
The negative human trial, which is where the field actually sits. A separate study reported failure of lysine in frequently recurrent herpes simplex infection Simon 1985. The review that tried to reconcile the literature found the split is largely a dose split: below 1 g a day lysine is ineffective, and above about 3 g a day it appears to improve the subjective experience of recurrences Mailoo 2017.
The obstacle is the dose, and it is a factor of two or three against you. The Thorne product this page points at is 500 mg of L-lysine per capsule, directed at one capsule two to three times daily NIH Office of Dietary Supplements 2026. That is 1.0–1.5 g a day at the top of the label — half of Griffith's regimen Griffith 1987 and half of the review's own 3 g threshold Mailoo 2017. Most people taking lysine and concluding it does nothing have never taken the tested dose.
The second obstacle is the endpoint's shape. Recurrence rate is a rate, which is why the positive trial ran for six months Griffith 1987. A rate cannot be estimated from a single interval, and herpes simplex clusters and then goes quiet for reasons of its own.
And the third is that nothing was measured. No lysine trial has ever reported a plasma lysine-to-arginine ratio alongside its outcome. Sixty years after the founding experiment, the mechanism has never been shown to be engaged in a person who responded.
L-Lysine — which form, and does it matter
Read whether the label states lysine or the salt. What is sold is almost always L-lysine monohydrochloride, and the hydrochloride is roughly a fifth of the molecular weight. The filed label for the product on this page states 500 mg of L-lysine as the monohydrochloride NIH Office of Dietary Supplements 2026 — that is elemental lysine, which is the honest way to write it. A label reading “500 mg L-lysine HCl” is offering about 400 mg of lysine, and over a 3 g target that difference is a whole capsule.
Timing is a mechanism, not a nicety. The argument is a ratio. Protein food arrives carrying both amino acids together, so a lysine capsule taken with a meal is partly canceled by the arginine in that meal. Away from food, on an empty stomach, is where the ratio moves furthest, and that is what the mechanism predicts even though no trial has tested it.
The pairing that defeats the product by its own logic. Arginine and citrulline supplements, and the arginine-rich foods — nuts, seeds, chocolate — move the ratio the other way. A lysine capsule taken beside a citrulline pre-workout is self-canceling on the mechanism the capsule is sold on Tankersley 1964.
Topical is not the evidenced route. Lysine creams and lip balms exist; the trials are oral Griffith 1987 Simon 1985, and there is no reason from the transporter argument to expect a topical amino acid to change intracellular ratios in epithelium.
One database note worth knowing. Every filed label for the Thorne L-Lysine linked from this page is recorded in the NIH Dietary Supplement Label Database as off market, the most recent as of 30 November 2022 NIH Office of Dietary Supplements 2026. If you buy a different brand, check the elemental lysine per capsule before assuming the dose carries across.
What would have to be true, and how you would know it was not
1. The dose prediction, which is the most useful thing on this page. Predict that 1 g a day does nothing detectable and that 3 g a day split into three doses is the only regimen with a positive randomized trial behind it Griffith 1987 Mailoo 2017. If you are going to test this on yourself, test the dose that was tested. Six months, because the endpoint is a rate.
2. The prediction that cuts against the product. Predict no effect on an outbreak that has already started. Griffith's design was six months of continuous prophylaxis Griffith 1987; nothing in the literature supports starting lysine at the tingle and expecting the blister to be aborted. The product most people buy for treatment has its evidence in prevention.
3. Predict nothing on any routine blood test. Plasma lysine would move on a 3 g dose and no standard panel reports it. There is no marker to follow, which is why the calendar is the instrument here.
4. The interaction prediction, and it is testable at home. Predict that adding arginine or citrulline abolishes any benefit you were getting. If you are on both and lysine seems to work, stopping the arginine should make it work better — and if it makes no difference, the mechanism is not what is producing your result.
5. The dose ceiling. Predict loose stools somewhere above about 6 g a day Flodin 1997. That is the practical upper bound on any self-experiment, and it arrives before any interesting territory.
What nobody has tested yet
Nobody has measured the ratio the whole theory rests on. A trial that reported plasma lysine and plasma arginine alongside recurrence counts would establish whether responders are the people whose ratio actually moved Tankersley 1964. It has never been done, and it is two extra tubes of blood.
There has never been a dose-ranging trial. One gram against three grams against six grams against placebo, six months, recurrence count as the endpoint. The 3 g threshold in the literature is inferred by comparing across trials that differed in a dozen other ways Mailoo 2017, which is the weakest way to establish a dose.
Nobody has tested the dietary version. A lysine-rich, arginine-sparing diet against a capsule, at matched ratios, would say whether the effect belongs to the supplement or to the ratio — and would be cheaper for whoever it works for.
And nobody has tested it alongside the actual treatment. People with frequent recurrences are offered suppressive antiviral therapy, which works. Whether lysine adds anything on top of valacyclovir has never been studied, which means the question every patient with frequent outbreaks would actually ask has no answer.
L-Lysine — its own safety story, not its category's
The dose-limiting effect is the gut. Gastrointestinal upset and diarrhea appear above roughly 6 g a day Flodin 1997, which is comfortably above the 3 g regimen that has evidence behind it Griffith 1987. There is no established upper limit and no long-term toxicology in humans beyond the six-month trials.
The kidney caution, argued from the transporter rather than from a warning label. Lysine is a dibasic amino acid, handled in the renal tubule by the same transport system as arginine, ornithine and cystine — the system whose failure defines cystinuria. Loading it raises dibasic amino acid excretion. In normal kidneys that is uneventful; in reduced renal function, or in anyone who forms cystine stones, it is a reason to leave this alone.
The calcium point, which is usually printed as a benefit. Lysine is described as increasing calcium absorption Flodin 1997. If that is real, then on top of a calcium supplement it is an addition to a total load rather than a bonus, and it matters to anyone with hypercalcemia or a history of calcium stones.
The one drug interaction worth flagging is with aminoglycoside antibiotics, where the concern is additive renal stress. That is a short list of hospital drugs, and if you are on one, this is not the week to start an amino acid.
And the clinical boundary. Cold sores that are frequent, severe, spreading, near the eye, or occurring in someone immunosuppressed are a prescription conversation, not a supplement one. Herpes keratitis threatens sight and is an ophthalmic emergency. Lysine's own best evidence is a 2.4-episode reduction over six months Griffith 1987; antivirals do considerably better than that and have been shown to.
L-Lysine safety basics3 points of its own
Its own safety story
- GI upset and diarrhea at high doses (above about 6 g).
- It competes with arginine, which is how it works for cold sores — and which means it can reduce arginine's effects if you take both.
- May raise calcium absorption; caution with calcium supplements and in hypercalcemia. Caution with kidney disease. Interacts with aminoglycoside antibiotics (additive kidney risk).
Not medical advice. If you take prescription medication or have a diagnosed condition, check this against it with a pharmacist or doctor. Pharmacists are underused and free.
Bloodwork to run4 tests in one order, code CAMERON
The effect itself has no blood test. That is a fact about the effect, and it changes how you should judge it.
- What to watchCold sores, counted as episodes rather than remembered as a season: the date each one starts, whether it gets past the tingle to a blister, and how many days from first tingle to healed skin. Those three are what the recurrence trials measured, and all three fit on a calendar.
- How long before it means anythingSix months of daily dosing, because the outcome is a rate. Herpes simplex recurrences cluster and then go quiet on their own, so a two-month run that happened to be quiet tells you nothing. You need episodes on both sides of the start date to compare.
- What will fool youThe gap. Almost everyone starts lysine during an outbreak, when the next one was always going to be weeks away, so the quiet stretch that follows is the rhythm of the virus rather than the amino acid. Sunlight on the lips, illness and stress are the real triggers and they move with the seasons. If outbreaks are frequent, severe, or anywhere near an eye, that is a prescription antiviral conversation with a doctor rather than a supplement question.
The labs mapped to L-Lysine
Code CAMERON applies automatically at checkout. Draw before you start, not after: a result with nothing to compare it to answers nothing.
L-Lysine FAQ5 common questions
- What is L-Lysine?
- An essential amino acid needed for collagen, carnitine synthesis and calcium absorption, best known for supporting the body against cold-sore (herpes simplex) outbreaks.
- What is the suggested dose of L-Lysine?
- 1–3 g daily (higher during outbreaks) away from arginine-rich meals. This is a general reference for education only. Statements have not been evaluated by the FDA and this is not medical advice.
- Who is L-Lysine for?
- Cold-sore/HSV support, collagen and general amino balance.
- Which labs show whether L-Lysine is doing anything?
- Complete Blood Count (CBC) with Differential, Vitamin D (25-Hydroxy), Zinc, Plasma, Comprehensive Metabolic Panel (CMP). Draw a baseline before you start, then recheck.
- Where can I buy L-Lysine?
- Coach Cam sources L-Lysine from Thorne, with 10% off applied automatically at checkout. Use the buy link on this page.



